Literature DB >> 30394690

Sulodexide in venous disease.

B J Carroll1, G Piazza2, S Z Goldhaber2.   

Abstract

Sulodexide is a glycosaminoglycan extracted from porcine intestinal mucosa. The purpose of this review is to discuss sulodexide's complex pharmacological profile and its clinical applications for venous disease. Sulodexide has wide-ranging biological effects on the vascular system, including antithrombotic, profibrinolytic, anti-inflammatory, endothelial protective and vasoregulatory effects. Sulodexide has emerged as a potential therapeutic option for the management of chronic venous insufficiency, including venous ulceration, and the prevention of recurrent venous thromboembolism, with a low rate of major bleeding complications. Sulodexide's pleiotropic vascular effects may facilitate the management of common venous disorders.
© 2018 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  anticoagulants; endothelium; post-thrombotic syndrome; varicose ulcer; venous thromboembolism

Mesh:

Substances:

Year:  2018        PMID: 30394690     DOI: 10.1111/jth.14324

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

1.  Albumin, oral contraceptives, and venous thromboembolism risk in astronauts.

Authors:  Sara R Zwart; Serena M Auñón-Chancellor; Martina Heer; M Mark Melin; Scott M Smith
Journal:  J Appl Physiol (1985)       Date:  2022-04-07

2.  Sulodexide increases mRNA expression of glutathione-related genes in human umbilical endothelial cells exposed to oxygen-glucose deprivation.

Authors:  Bożena Gabryel; Klaudia Bontor; Tomasz Urbanek
Journal:  Arch Med Sci       Date:  2019-08-27       Impact factor: 3.318

3.  Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation.

Authors:  Douglas D Fraser; Eric K Patterson; Marat Slessarev; Sean E Gill; Claudio Martin; Mark Daley; Michael R Miller; Maitray A Patel; Claudia C Dos Santos; Karen J Bosma; David B O'Gorman; Gediminas Cepinskas
Journal:  Crit Care Explor       Date:  2020-08-24

4.  Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components.

Authors:  Fakiha Siddiqui; Debra Hoppensteadt; Emily Bontekoe; Ambar Farooqui; Walter Jeske; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  Mendelian randomization analysis of plasma levels of CD209 and MICB proteins and the risk of varicose veins of lower extremities.

Authors:  Alexandra S Shadrina; Elizaveta E Elgaeva; Ian B Stanaway; Gail P Jarvik; Bahram Namjou; Wei-Qi Wei; Joe Glessner; Hakon Hakonarson; Pradeep Suri; Yakov A Tsepilov
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

6.  Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis.

Authors:  Angelo A Bignamini; Ahmed Chebil; Giovanni Gambaro; Jiří Matuška
Journal:  Adv Ther       Date:  2021-01-27       Impact factor: 3.845

7.  Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.

Authors:  Monika Misian; Ewa Baum; Andrzej Bręborowicz
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

8.  Sulodexide Increases Glutathione Synthesis and Causes Pro-Reducing Shift in Glutathione-Redox State in HUVECs Exposed to Oxygen-Glucose Deprivation: Implication for Protection of Endothelium against Ischemic Injury.

Authors:  Klaudia Bontor; Bożena Gabryel
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

9.  Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.

Authors:  Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Dulce Papy-García; Denis Barritault; Edgar Zenteno; Luis Manuel Sánchez Navarro; Eduardo Pérez-Campos Mayoral; Carlos Alberto Matias Cervantes; Margarito Martínez Cruz; Gabriel Mayoral Andrade; Malaquías López Cervantes; Gabriela Vázquez Martínez; Claudia López Sánchez; Socorro Pina Canseco; Ruth Martínez Cruz; Eduardo Pérez-Campos
Journal:  Mol Cell Biochem       Date:  2021-06-10       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.